+91-8668442535

Intravenous Access Devices Market By Product (Peripheral Vascular Access System and Central Vascular Access System), By Application (Medication Administration, Administration of Fluid and Nutrition, Transfusion of Blood Products and Diagnostic Testing) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

The Royal Children’s Hospital in Melbourne has devised an effective nursing guideline for the management of intravenous access devices in outpatient and home care settings. Aseptic techniques should be employed when placing the intravenous access devices in the blood veins with precise positioning to prevent complications such as phlebitis, extravasation, infiltration, and hematoma. The intravenous cannula should be protected by dressing the site of insertion, placing a cotton ball underneath the hub of the cannula to reduce pressure, and covering the cannula site with sterile occlusive dressings to prevent infection.

The intravenous access devices market comprises products such as peripheral vascular access systems and central vascular access systems. Medication administration, administration of fluid and nutrition, transfusion of blood products, and diagnostic testing are included in the applications segment. Market estimation and data forecasts for the product and application segments are provided for 2015-2025.

For the geographic segmentation, the data forecast and market estimation are included in the scope of the report.

The competitive landscape elucidates the competition in the intravenous access devices market and the different strategies employed by the major players to capitalize on the market. The attractive investment proposition model gives a clear idea while considering the regional market as an investment destination. The business milieu in the intravenous access market is understood by the cardinal players in the intravenous access devices market: GE Healthcare, Inc., Baxter International, Inc., B. Braun Medical, Inc., Becton Dickinson and Company, Edward Life Sciences Corporation, Medtronic Plc, Nipro Medical Corporation, Terumo Corporation, Teleflex Medical, and Siemens Medical Solutions, Inc.

Based on product, the global intravenous access devices market is categorized into:

Peripheral Vascular Access System

  • Peripheral Catheter
  • Midline Catheter

Central Vascular Access System

  • Central Vascular Catheter
  • Implanted Ports

Intravenous cannulation is a procedure in which the cannula is placed inside the veins, providing intravenous access for the administration of parenteral nutrition, blood sampling, IV fluids, and chemotherapy medicines. The veins have a three-layered wall composed of internal endothelium surrounded by thin layers of muscle fibers and connective tissues; understanding vein morphology is important in the manufacturing of catheters, or it might lead to major complications such as thrombophlebitis, air embolism, extravasation, and hematoma.

The peripheral vascular access system has a huge demand for short-term therapies like the administration of antipyretics, analgesics, and antibiotics and for collecting blood samples for diagnostic purposes. The central vascular access system is finding huge demand for long-term therapies such as chemotherapy, cardiovascular disease treatment, and parenteral nutrition. Major players in the intravenous access devices market are Baxter International, Inc., B. Braun Medical, Inc., Becton Dickinson and Company, Edward Life Sciences Corporation, GE Healthcare, Inc., Medtronic Plc, Nipro Medical Corporation, Siemens Medical Solutions, Inc., Teleflex Medical, and Terumo Corporation.

Based on application, the global intravenous access devices market is categorized as follows:

  • Medication Administration
  • administration of fluid and nutrition
  • Transfusion of blood products
  • Diagnostic Testing

According to a report published by the World Health Organization, globally, cancer is the second leading cause of death. In 2015, around 8.8 million people died due to cancer because the patients did not have access to effective chemotherapy. Chronic diseases such as cardiac complications, lung disorders, and diabetes are responsible for 60% of deaths globally. Medication administration and diagnostic testing together dominate the application segment as they are driven by the rising prevalence of chronic diseases requiring immediate intravenous drug delivery and the withdrawal of blood samples for the diagnosis of contagious diseases such as malaria, dengue, and water-borne diseases.

The administration of fluids and nutrition and the transfusion of blood products is set to grow rapidly due to the increasing number of cases of traumatic accidents resulting in heavy blood loss. Fluid and nutrition administration will accelerate market growth because intravenous administration is necessary to treat disorders such as typhoid, cholera, malnutrition, etc., which, if unchecked, can result in the death of an ailing patient.

For the purpose of this study, the global intravenous access devices market is categorized into the following regional and country-specific markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Advanced diagnostic screening and the domicile of prominent manufacturers are responsible for the superiority of North America in the intravenous access devices market. The intravenous access devices market seeks lucrative market growth in Europe due to the presence of rare blood disorder diseases that necessitate frequent blood transfusions and a high-risk incidence of communicable diseases as a result of the recent immigration influx. The hot and humid weather conditions in the Asia Pacific are to blame for the rise in tropical disease, which necessitates the administration of intravenous medication right away.

The presence of existing and budding companies manufacturing intravenous access devices is expected to contribute to impressive growth in the Asia-Pacific region in the near future. The World Health Organization and Red Cross are actively involved in the provision of intravenous access devices to the Middle East and Africa region to fight life-threatening diseases. Because of the proactive role of government health agencies in establishing primary healthcare centers throughout Latin America, there is a high demand for intravenous access devices in the region. 

Frequently Asked Questions:

The market for Intravenous Access Devices Market is expected to reach US$ 7,918.12 Mn by 2025.

The Intravenous Access Devices Market is expected to see significant CAGR growth over the coming years, at 5.1%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Baxter International, Inc., B. Braun Medical, Inc., Becton Dickinson and Company, Edward Life Sciences Corporation, GE Healthcare, Inc., Medtronic Plc, Nipro Medical Corporation, Siemens Medical Solutions, Inc., Teleflex Medical are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58843
Report Format:   PDF
Pages:   120
Rating:    4.8 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support